Clinical and Functional Profile of Patients with Severe Eosinophilic Asthma with Rapid Response to Benralizumab Therapy (Super-Responders): A Single-Center Retrospective Study.
Benralizumab therapy for severe eosinophilic asthma demonstrates a heterogeneous clinical response. Identification of patients who rapidly achieve clinical remission and analysis of their baseline characteristics are essential for the personalization of biologic therapy. AIMSto characterize the clinical and functional...